Sanomedics
International Holdings focuses on providing products, services and ideas
through collaborative efforts between physicians, entrepreneurs, and medical
companies. Together these groups bridge the gap between the high-technology
medical world and the home healthcare environment. The net result is one that
drives innovative technologies from concept to development, and ultimately
revenue producing market sales. Sanomedics plans to grow its business through
acquisitions, operating within the sleep disorder diagnosis treatments space.
SIMH is active in its pursuit to acquire sleep therapy operating businesses.
Its strategy involves integrating a portfolio of world-class products and
service providers in the growing sleep apnea market. Its goal is to provide
sleep apnea patients with a reliable “end-to-end” solution.
The market
opportunity appears to be bright as sleep apnea is estimated to affect about 4%
of men and 2% of women. In one study referenced at MedicineNet.com of people
over 18 years of age, “obstructive sleep apnea was estimated to develop in 1.5%
of people per year over the 5 year study. It is probably more common than
either of these numbers because the population is becoming more obese, and
obesity worsens obstructive sleep apnea.”
Within the
highly competitive, preventative medicine marketplace, investors can rest
assured Sanomedics is engaged in activity necessary for its financial health
and viability. The company has just announced its liabilities have been reduced
by 8% and in so doing has strengthened its balance sheet following the
restructure of $1 Million, plus interest, in debt owed to TCA Global Credit Master
Fund LP (“TCA”). The restructure of its TCA debt was announced in a press
release and a Form 8-K filed with the Securities and Exchange Commission on
September 29, 2014.
Sanomedics
President, Keith Houlihan, added, “Our plans to build a solid foundation and
strengthen the value of this company and its balance sheet, while garnering
financial flexibility have not wavered in the slightest. Rather, they have been
re-energized with this modest, but significant improvement in our liabilities.
We remain committed to putting this company on the right path to long term
growth and appreciation for benefit of not only Sanomedics and our
shareholders, but also those in the healthcare industry that need innovative
solutions to meet the patient care and safety demands that come with our
growing and aging population.”
Additionally,
SIMH designs, develops, markets, and distributes a line of non-contact clinical
thermometers in the United States. The company’s products are served to the
market under the Caregiver name to healthcare providers. This group includes
hospitals, medical clinics, physician’s offices, assisted living facilities,
acute care hospitals, and a variety of long-term care institutions. It sells
its products through distributors, resellers, and sales representatives and is
located in Miami, Florida.
For more
information on the company, visit www.sanomedics.com
About QualityStocks
QualityStocks
is committed to connecting subscribers with companies that have huge potential
to succeed in the short and long-term future. We offer several ways for
investors to find, evaluate, and learn more about investing in these companies.
Sign up
for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The
Quality Stocks Daily Blog http://blog.qualitystocks.net
The
Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The
Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
No comments:
Post a Comment